TFCP
MRNA icon

Twin Focus Capital Partners’s Moderna MRNA Stock Holding History

Twin Focus Capital Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Hold
185,601
– – 1.32% 16
2026
Q1 		$9.43M Buy
185,601
+121
+0.1% +$5.64K 1.08% 24
2025
Q4 		$5.47M Buy
+185,480
New +$5.04M 0.63% 39
2021
Q4 		– Sell
-552
Closed -$212K – 230
2021
Q3 		$212K Buy
+552
New +$204K 0.05% 174

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Twin Focus Capital Partners's MRNA Position: Q2 2026 in Review

Twin Focus Capital Partners held its Moderna (MRNA) position steady in Q2 2026 at 185,601 shares worth $13M. The position accounts for 1.32% of the portfolio, ranked #16.

Twin Focus Capital Partners first reported a position in MRNA in Q3 2021 and has held it in 4 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Twin Focus Capital Partners held 185,601 shares of Moderna worth $13M as of Q2 2026.
  • Twin Focus Capital Partners left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 1.32% of Twin Focus Capital Partners's portfolio in Q2 2026, its #16 holding.
  • Twin Focus Capital Partners first reported a position in Moderna in Q3 2021 and has held it in 4 quarters since.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Twin Focus Capital Partners's 13F filing for Q2 2026, filed 28 Jul 2026.